Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825149 | SCV000966416 | likely benign | not specified | 2018-04-17 | criteria provided, single submitter | clinical testing | p.Pro1332Leu in exon 42 of the COL4A4 gene: This variant is not expected to have clinical significance due to a lack of conservation across species, including m ammals. Proline (Pro) at position 1332 is not conserved in mammals or evolutiona rily distant species and >10 mammals/species carry a leucine (Leu), supporting t hat this change may be tolerated. Additional computational tools suggest that t he p.Pro1332Leu variant may not impact the protein. This variant has been identi fied in 7/23716 of African chromosomes by the Genome Aggregation Database (gnomA D, http://gnomad.broadinstitute.org; dbSNP rs200860702). ACMG/AMP Criteria appli ed: BP4_Strong. |
Gene |
RCV001840737 | SCV002099623 | uncertain significance | not provided | 2022-02-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001840737 | SCV002285042 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271498 | SCV001452702 | uncertain significance | Alport syndrome | 2020-03-17 | no assertion criteria provided | clinical testing |